Curis
CRIS
#10201
Rank
C$24.36 M
Marketcap
C$1.88
Share price
0.00%
Change (1 day)
-65.97%
Change (1 year)

Curis (CRIS) - Net assets

Net assets on the balance sheet as of September 2025 : -C$20.51 Million

According to Curis's latest financial reports the company has -C$20.51 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Curis - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-C$8.61 Million-132.99%
2023-12-31$C$26.08 M-58.7%
2022-12-31$C$63.16 M-45.36%
2021-12-31$C$0.11 B-30.62%
2020-12-31$C$0.16 B-476.19%
2019-12-31$-C$44.29 Million623.16%
2018-12-31$-C$6.13 Million-120.3%
2017-12-31$C$30.16 M-23.3%
2016-12-31$C$39.32 M-56.05%
2015-12-31$C$89.48 M158.91%
2014-12-31$C$34.56 M-28.12%
2013-12-31$C$48.08 M41.12%
2012-12-31$C$34.07 M-15.99%
2011-12-31$C$40.56 M-10.85%
2010-12-31$C$45.49 M30.83%
2009-12-31$C$34.77 M-23.16%
2008-12-31$C$45.26 M-3.15%
2007-12-31$C$46.73 M11.81%
2006-12-31$C$41.79 M-5.53%
2005-12-31$C$44.24 M-23.76%
2004-12-31$C$58.02 M15.1%
2003-12-31$C$50.41 M72.15%
2002-12-31$C$29.28 M-81.8%
2001-12-31$C$0.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Exelixis
EXEL
C$3.01 B-14,807.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.81 B-4,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$37.41 M-282.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.83 B-4,172.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$129.95 B-633,794.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.96 B-126,708.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$9.8 M-147.82%๐Ÿ‡บ๐Ÿ‡ธ USA